NASDAQ:MDTH - MedCath Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedCath Corporation (MedCath) is a healthcare provider and focused on providing acuity services, including the diagnosis and treatment of cardiovascular disease. The Company owns and operates hospitals in partnership with physicians. Each of its majority-owned hospitals provides a range of health services with a focus on cardiovascular care. Each of its hospitals has around the clock-hour emergency room staffed by emergency department physicians. As of September 30, 2010, it owed interests in seven hospitals, including six in which it owned a majority interest. On November 1, 2010, the Company sold Heart Hospital of Austin. On December 31, 2010, the Company completed the sale of TexSan Heart Hospital to Methodist Healthcare System of San Antonio. On September 30, 2011, the Company sold Louisiana Medical Center & Heart Hospital to Cardiovascular Care Group. In December 2011, the Company announced that it has sold its ownership interest in Harlingen Medical Center and HMC Realty, LLC.

Receive MDTH News and Ratings via Email

Sign-up to receive the latest news and ratings for MDTH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:MDTH
CUSIPN/A
Phone+1-302-6587581

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

The Truth About Cryptocurrencies

MedCath (NASDAQ:MDTH) Frequently Asked Questions

What is MedCath's stock symbol?

MedCath trades on the NASDAQ under the ticker symbol "MDTH."

What is the consensus analysts' recommendation for MedCath?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedCath in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Has MedCath been receiving favorable news coverage?

Press coverage about MDTH stock has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MedCath earned a media sentiment score of 0.04 on Accern's scale. They also assigned headlines about the health services provider an impact score of 43.35 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

How do I buy shares of MedCath?

Shares of MDTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact MedCath?

MedCath's mailing address is Corporation Trust Center 1209 Orange Street, New Castle County, WILMINGTON, DE 19801, United States. The health services provider can be reached via phone at +1-302-6587581.


MarketBeat Community Rating for MedCath (NASDAQ MDTH)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  75
MarketBeat's community ratings are surveys of what our community members think about MedCath and other stocks. Vote "Outperform" if you believe MDTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDTH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.